Investor Relations

Webcast
Q1 2015 ResMed Inc. Earnings Conference Call (Live)
10/23/14 at 1:30 p.m. PT
About ResMed

ResMed ( NYSE: RMD and ASX: RMD.AX ) changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.

We develop innovative products to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing.   More

Stock Quote
ExchangeNYSE (US Dollar)
Price$46.77
Change (%) Stock is Up 0.52 (1.12%)
Volume1,649,000
Data as of 10/17/14 4:00 p.m. ET
Refresh quote
Stock Chart
Stock chart for: RMD
SEC Filings
Filing DateFormFiling GroupDownloads
10/17/1443,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
10/06/1443,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
10/06/1443,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
10/03/1443,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
Annual Reports
Download Documentation
2014 Annual Report (PDF, 586kb)
Download DocumentationReconciliation of Non-GAAP
Financial Measures (Unaudited)
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.